Radiother Oncol 2023 Aug
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.
Related Questions
New answer by Radiation Oncologist at UC San Diego (November 22, 2024)
Yes, it is reasonable to offer weekly prostate SBRT to patients.Quick review of evidence: hypo-FLAME 2.0 (De Cock et al., PMID 37178932) was a phase II single-arm trial that u...